The significance of human platelet-activating factor acetylhydrolase in patients with chronic stable angina
Background: Inflammatory reactions within coronary atherosclerotic plaques are increasingly thought to be crucial determinants of the clinical course of patients with coronary artery disease (CAD). Platelet activating factor-acetylhydrolase (PAF-AH) is considered to reflect the ongoing inflammatory process in patients with CAD. The objective is to determine the activity of PAF-AH in patients with stable angina and its correlations to the lipoproteins
Read more